- Home
- LZB vs TVTX Comparison
LZB vs TVTX Comparison
Compare LZB & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LZB
- TVTX
- Stock Information
- Founded
- LZB 1927
- TVTX 2008
- Country
- LZB United States
- TVTX United States
- Employees
- LZB N/A
- TVTX N/A
- Industry
- LZB Home Furnishings
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- LZB Consumer Discretionary
- TVTX Health Care
- Exchange
- LZB Nasdaq
- TVTX Nasdaq
- Market Cap
- LZB 1.6B
- TVTX 1.3B
- IPO Year
- LZB N/A
- TVTX N/A
- Fundamental
- Price
- LZB $38.41
- TVTX $17.43
- Analyst Decision
- LZB Hold
- TVTX Strong Buy
- Analyst Count
- LZB 1
- TVTX 13
- Target Price
- LZB N/A
- TVTX $33.75
- AVG Volume (30 Days)
- LZB 486.7K
- TVTX 1.8M
- Earning Date
- LZB 06-16-2025
- TVTX 05-05-2025
- Dividend Yield
- LZB 2.29%
- TVTX N/A
- EPS Growth
- LZB 7.87
- TVTX N/A
- EPS
- LZB 2.91
- TVTX N/A
- Revenue
- LZB $2,091,871,000.00
- TVTX $233,175,000.00
- Revenue This Year
- LZB $3.42
- TVTX $68.31
- Revenue Next Year
- LZB $3.50
- TVTX $55.65
- P/E Ratio
- LZB $13.17
- TVTX N/A
- Revenue Growth
- LZB 1.80
- TVTX 60.55
- 52 Week Low
- LZB $32.00
- TVTX $5.12
- 52 Week High
- LZB $48.31
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- LZB 47.87
- TVTX 49.57
- Support Level
- LZB $37.56
- TVTX $14.13
- Resistance Level
- LZB $39.81
- TVTX $15.23
- Average True Range (ATR)
- LZB 1.63
- TVTX 1.23
- MACD
- LZB 0.22
- TVTX 0.24
- Stochastic Oscillator
- LZB 71.71
- TVTX 82.21
About LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; and Retail, which sells upholstered and case goods furniture to the end consumer. The majority of the company's revenue is derived from its Wholesale segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.